Pub. Date : 2018 Aug 7
PMID : 30026287
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Annualized eGFR slopes of patients treated with tolvaptan did not change during follow-up and differences between observed and predicted eGFRs at last follow-up increased with duration of treatment. | Tolvaptan | epidermal growth factor receptor | Homo sapiens |
| 2 | CONCLUSIONS: Follow-up for up to 11.2 years (average 4.6 years) showed a sustained reduction in the annual rate of eGFR decline in patients treated with tolvaptan compared with controls and an increasing separation of eGFR values over time between the two groups. | Tolvaptan | epidermal growth factor receptor | Homo sapiens |
| 3 | CONCLUSIONS: Follow-up for up to 11.2 years (average 4.6 years) showed a sustained reduction in the annual rate of eGFR decline in patients treated with tolvaptan compared with controls and an increasing separation of eGFR values over time between the two groups. | Tolvaptan | epidermal growth factor receptor | Homo sapiens |